rs1143560
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_006009.4(TUBA1A):c.396C>T(p.Leu132Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00154 in 1,614,152 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 1 hom. )
Consequence
TUBA1A
NM_006009.4 synonymous
NM_006009.4 synonymous
Scores
16
Clinical Significance
Conservation
PhyloP100: -1.46
Publications
0 publications found
Genes affected
TUBA1A (HGNC:20766): (tubulin alpha 1a) Microtubules of the eukaryotic cytoskeleton perform essential and diverse functions and are composed of a heterodimer of alpha and beta tubulins. The genes encoding these microtubule constituents belong to the tubulin superfamily, which is composed of six distinct families. Genes from the alpha, beta and gamma tubulin families are found in all eukaryotes. The alpha and beta tubulins represent the major components of microtubules, while gamma tubulin plays a critical role in the nucleation of microtubule assembly. There are multiple alpha and beta tubulin genes, which are highly conserved among species. This gene encodes alpha tubulin and is highly similar to the mouse and rat Tuba1 genes. Northern blot studies have shown that the gene expression is predominantly found in morphologically differentiated neurologic cells. This gene is one of three alpha-tubulin genes in a cluster on chromosome 12q. Mutations in this gene cause lissencephaly type 3 (LIS3) - a neurological condition characterized by microcephaly, intellectual disability, and early-onset epilepsy caused by defective neuronal migration. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0052078366).
BP6
Variant 12-49185970-G-A is Benign according to our data. Variant chr12-49185970-G-A is described in ClinVar as Benign. ClinVar VariationId is 160155.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.46 with no splicing effect.
BS2
High AC in GnomAd4 at 214 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TUBA1A | NM_006009.4 | c.396C>T | p.Leu132Leu | synonymous_variant | Exon 4 of 4 | ENST00000301071.12 | NP_006000.2 | |
| TUBA1A | NM_001270399.2 | c.396C>T | p.Leu132Leu | synonymous_variant | Exon 4 of 4 | NP_001257328.1 | ||
| TUBA1A | NM_001270400.2 | c.291C>T | p.Leu97Leu | synonymous_variant | Exon 4 of 4 | NP_001257329.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00142 AC: 216AN: 152144Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
216
AN:
152144
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00165 AC: 414AN: 251410 AF XY: 0.00174 show subpopulations
GnomAD2 exomes
AF:
AC:
414
AN:
251410
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00155 AC: 2266AN: 1461890Hom.: 1 Cov.: 34 AF XY: 0.00159 AC XY: 1157AN XY: 727244 show subpopulations
GnomAD4 exome
AF:
AC:
2266
AN:
1461890
Hom.:
Cov.:
34
AF XY:
AC XY:
1157
AN XY:
727244
show subpopulations
African (AFR)
AF:
AC:
26
AN:
33480
American (AMR)
AF:
AC:
47
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
236
AN:
26136
East Asian (EAS)
AF:
AC:
26
AN:
39700
South Asian (SAS)
AF:
AC:
81
AN:
86258
European-Finnish (FIN)
AF:
AC:
74
AN:
53420
Middle Eastern (MID)
AF:
AC:
10
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
1650
AN:
1112008
Other (OTH)
AF:
AC:
116
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
153
305
458
610
763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00141 AC: 214AN: 152262Hom.: 1 Cov.: 32 AF XY: 0.00145 AC XY: 108AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
214
AN:
152262
Hom.:
Cov.:
32
AF XY:
AC XY:
108
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
23
AN:
41556
American (AMR)
AF:
AC:
18
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
27
AN:
3470
East Asian (EAS)
AF:
AC:
3
AN:
5188
South Asian (SAS)
AF:
AC:
3
AN:
4826
European-Finnish (FIN)
AF:
AC:
11
AN:
10622
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
120
AN:
68002
Other (OTH)
AF:
AC:
7
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
11
21
32
42
53
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
11
ExAC
AF:
AC:
197
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jan 13, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Oct 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
TUBA1A: BS1, BS2 -
Oct 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Benign
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
PhyloP100
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Vest4
MVP
ClinPred
T
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.